Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 2009 Jun 08; 27(28):3766-74.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.